Tag: Amyn Amlani

OTC, Hearing Aids, and Cost as a Barrier to Purchase: An Interview with Amyn M. Amlani, PhD

The argument that a new FDA class of OTC hearing aids will dramatically expand the hearing healthcare market by making hearing aids more affordable is often taken as a “given.” However, research into what economists call “price elasticity”—or how much growth occurs in terms of market penetration when the cost of a product is reduced/increased—tend to suggest otherwise when it comes to hearing aids.

Read More

Improving Patient Perception of Clinical Services Through Real-ear Measurements

This study assessed the impact of REMs on consumer satisfaction as a service component during hearing aid fittings. For the SERVAL scale, overall results revealed that the REM protocol reduced emotional distress, and improved perceived quality of service and value of the fitting compared to the Quick-fit protocol in 3 groups of participants.

Read More